The global Biologics Market was valued at USD 356.4 billion in 2022 and is expected to reach USD 712.45 billion in 2032, with a compound annual growth rate of 8% during the forecast period. The market is being driven by factors such as an increasing prevalence of chronic diseases, rising demand for personalized medication, and the growing elderly population.
Biologics are complex...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian